ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Correlation of Human Jejunal Permeability (in Vivo) of Drugs with Experimentally and Theoretically Derived Parameters. A Multivariate Data Analysis Approach

View Author Information
Department of Organic Pharmaceutical Chemistry and Department of Pharmacy, Uppsala Biomedical Centre, Uppsala University, SE-751 23 Uppsala, Sweden
Cite this: J. Med. Chem. 1998, 41, 25, 4939–4949
Publication Date (Web):November 7, 1998
Copyright © 1998 American Chemical Society

    Article Views





    Other access options
    Supporting Info (1)»


    The effective permeability (Peff) in the human jejunum (in vivo) of 22 structurally diverse compounds was correlated with both experimentally determined lipophilicity values and calculated molecular descriptors. The permeability data were previously obtained by using a regional in vivo perfusion system in the proximal jejunum in humans as part of constructing a biopharmaceutical classification system for oral immediate-release products. pKa, log P, and, where relevant, log Pion values were determined using the pH-metric technique. On the basis of these experiments, log D values were calculated at pH 5.5, 6.5, and 7.4. Multivariate data analysis was used to derive models that correlate passive intestinal permeability to physicochemical descriptors. The best model obtained, based on 13 passively transcellularly absorbed compounds, used the variables HBD (number of hydrogen bond donors), PSA (polar surface area), and either log D5.5 or log D6.5 (octanol/water distribution coefficient at pH 5.5 and 6.5, respectively). Statistically good models for prediciting human in vivo Peff values were also obtained by using only HBD and PSA or HBD, PSA, and CLOGP. These models can be used to predict passive intestinal membrane diffusion in humans for compounds that fit within the defined property space. We used one of the models obtained above to predict the log Peff values for an external validation set consisting of 34 compounds. A good correlation with the absorption data of these compounds was found.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

     Department of Organic Pharmaceutical Chemistry.

     Department of Pharmacy.


    In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.

    Supporting Information Available

    Jump To

    Data used in the multivariate data analysis for data set 1 (1 page). Ordering information is given on any current masthead page.

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:

    Cited By

    This article is cited by 354 publications.

    1. Dahlia R. Weiss, Javier L. Baylon, Ethan D. Evans, Anthony Paiva, Gerry Everlof, Jingfang Cutrone, Fabio Broccatelli. Balanced Permeability Index: A Multiparameter Index for Improved In Vitro Permeability. ACS Medicinal Chemistry Letters 2024, 15 (4) , 457-462.
    2. Stephen D. Stamatis, John P. Rose. Lilly Absorption Modeling Platform: A Tool for Early Absorption Assessment. Molecular Pharmaceutics 2022, 19 (1) , 213-226.
    3. Edward Price, J. Cory Kalvass, David DeGoey, Balakrishna Hosmane, Stella Doktor, Kelly Desino. Global Analysis of Models for Predicting Human Absorption: QSAR, In Vitro, and Preclinical Models. Journal of Medicinal Chemistry 2021, 64 (13) , 9389-9403.
    4. Mark T. Schnepper, Jeff Roles, James J. Hickman. Characterization of Drug–Polymer Adsorption Isotherms in Body-on-a-Chip Systems by Inverse Liquid–Solid Chromatography. ACS Biomaterials Science & Engineering 2020, 6 (8) , 4462-4475.
    5. Patrick D. Sinko, Sarah Harris, Niloufar Salehi, Pamela J. Meyer, Gordon L. Amidon, Gregory E. Amidon. Ultrathin, Large-Area Membrane Diffusion Cell for pH-Dependent Simultaneous Dissolution and Absorption Studies. Molecular Pharmaceutics 2020, 17 (7) , 2319-2328.
    6. Stephanie A. Brocke, Alexandra Degen, Alexander D. MacKerell, Jr., Bercem Dutagaci, Michael Feig. Prediction of Membrane Permeation of Drug Molecules by Combining an Implicit Membrane Model with Machine Learning. Journal of Chemical Information and Modeling 2019, 59 (3) , 1147-1162.
    7. Michael D. Shultz. Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs. Journal of Medicinal Chemistry 2019, 62 (4) , 1701-1714.
    8. Carl Roos, David Dahlgren, Erik Sjögren, Christer Tannergren, Bertil Abrahamsson, and Hans Lennernäs . Regional Intestinal Permeability in Rats: A Comparison of Methods. Molecular Pharmaceutics 2017, 14 (12) , 4252-4261.
    9. David Dahlgren, Carl Roos, Anders Lundqvist, Christer Tannergren, Peter Langguth, Markus Sjöblom, Erik Sjögren, and Hans Lennernäs . Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA. Molecular Pharmaceutics 2017, 14 (12) , 4243-4251.
    10. Bart Hens, Shriram M. Pathak, Amitava Mitra, Nikunjkumar Patel, Bo Liu, Sanjaykumar Patel, Masoud Jamei, Joachim Brouwers, Patrick Augustijns, and David B. Turner . In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole. Molecular Pharmaceutics 2017, 14 (12) , 4321-4333.
    11. Patrick D. Sinko, David Gidley, Richard Vallery, Aaron Lamoureux, Gordon L. Amidon, and Gregory E. Amidon . In Vitro Characterization of the Biomimetic Properties of Poly(dimethylsiloxane) To Simulate Oral Drug Absorption. Molecular Pharmaceutics 2017, 14 (12) , 4661-4674.
    12. Franco Lombardo, Prashant V. Desai, Rieko Arimoto, Kelly E. Desino, Holger Fischer, Christopher E. Keefer, Carl Petersson, Susanne Winiwarter, and Fabio Broccatelli . In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development. Journal of Medicinal Chemistry 2017, 60 (22) , 9097-9113.
    13. Linda Fredlund, Susanne Winiwarter, and Constanze Hilgendorf . In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development. Molecular Pharmaceutics 2017, 14 (5) , 1601-1609.
    14. F. Broccatelli, L. Salphati, E. Plise, J. Cheong, A. Gobbi, M.-L. Lee, and I. Aliagas . Predicting Passive Permeability of Drug-like Molecules from Chemical Structure: Where Are We?. Molecular Pharmaceutics 2016, 13 (12) , 4199-4208.
    15. David Dahlgren, Carl Roos, Anders Lundqvist, Bertil Abrahamsson, Christer Tannergren, Per M. Hellström, Erik Sjögren, and Hans Lennernäs . Regional Intestinal Permeability of Three Model Drugs in Human. Molecular Pharmaceutics 2016, 13 (9) , 3013-3021.
    16. David Dahlgren, Carl Roos, Pernilla Johansson, Anders Lundqvist, Christer Tannergren, Bertil Abrahamsson, Erik Sjögren, and Hans Lennernäs . Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms. Molecular Pharmaceutics 2016, 13 (9) , 3022-3033.
    17. Erik Sjögren, David Dahlgren, Carl Roos, and Hans Lennernäs . Human in Vivo Regional Intestinal Permeability: Quantitation Using Site-Specific Drug Absorption Data. Molecular Pharmaceutics 2015, 12 (6) , 2026-2039.
    18. Hans Lennernäs . Human in Vivo Regional Intestinal Permeability: Importance for Pharmaceutical Drug Development. Molecular Pharmaceutics 2014, 11 (1) , 12-23.
    19. Danielle Newby, Alex. A. Freitas, and Taravat Ghafourian . Pre-processing Feature Selection for Improved C&RT Models for Oral Absorption. Journal of Chemical Information and Modeling 2013, 53 (10) , 2730-2742.
    20. Lele Zhao, Danyan Cao, Tiantian Chen, Yingqing Wang, Zehong Miao, Yechun Xu, Wuyan Chen, Xin Wang, Yanlian Li, Zhiyan Du, Bing Xiong, Jian Li, Chunyan Xu, Naixia Zhang, Jianhua He, and Jingkang Shen . Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain. Journal of Medicinal Chemistry 2013, 56 (10) , 3833-3851.
    21. Sophia Y. K. Fong, Mary Liu, Hai Wei, Raimar Löbenberg, Isadore Kanfer, Vincent H. L. Lee, Gordon L. Amidon, and Zhong Zuo . Establishing the Pharmaceutical Quality of Chinese Herbal Medicine: A Provisional BCS Classification. Molecular Pharmaceutics 2013, 10 (5) , 1623-1643.
    22. Jane P. F. Bai, Ethan Hausman, Robert Lionberger, and Xinyuan Zhang . Modeling and Simulation of the Effect of Proton Pump Inhibitors on Magnesium Homeostasis. 1. Oral Absorption of Magnesium. Molecular Pharmaceutics 2012, 9 (12) , 3495-3505.
    23. Sara Carlert, Pernilla Åkesson, Gunilla Jerndal, Lennart Lindfors, Hans Lennernäs, and Bertil Abrahamsson . In Vivo Dog Intestinal Precipitation of Mebendazole: A Basic BCS Class II Drug. Molecular Pharmaceutics 2012, 9 (10) , 2903-2911.
    24. Aaron M. Moss, Christopher J. Endres, Ana Ruiz-Garcia, Doo-Sup Choi, and Jashvant D. Unadkat . Role of the Equilibrative and Concentrative Nucleoside Transporters in the Intestinal Absorption of the Nucleoside Drug, Ribavirin, in Wild-Type and Ent1(−/−) Mice. Molecular Pharmaceutics 2012, 9 (9) , 2442-2449.
    25. Margaret R. McLellan, M. Dominic Ryan, and Curt M. Breneman . Rank Order Entropy: Why One Metric Is Not Enough. Journal of Chemical Information and Modeling 2011, 51 (9) , 2302-2319.
    26. Wieslaw M. Kazmierski, Don L. Anderson, Christopher Aquino, Brian A. Chauder, Maosheng Duan, Robert Ferris, Terrence Kenakin, Cecilia S. Koble, Dan G. Lang, Maggie S Mcintyre, Jennifer Peckham, Christian Watson, Pat Wheelan, Andrew Spaltenstein, Mary B. Wire, Angilique Svolto, and Michael Youngman . Novel 4,4-Disubstituted Piperidine-Based C–C Chemokine Receptor-5 Inhibitors with High Potency against Human Immunodeficiency Virus-1 and an Improved human Ether-a-go-go Related Gene (hERG) Profile. Journal of Medicinal Chemistry 2011, 54 (11) , 3756-3767.
    27. Claudia Suenderhauf, Felix Hammann, Andreas Maunz, Christoph Helma, and Jörg Huwyler . Combinatorial QSAR Modeling of Human Intestinal Absorption. Molecular Pharmaceutics 2011, 8 (1) , 213-224.
    28. Tobias Klein, Daniela Abgottspon, Matthias Wittwer, Said Rabbani, Janno Herold, Xiaohua Jiang, Simon Kleeb, Christine Lüthi, Meike Scharenberg, Jacqueline Bezençon, Erich Gubler, Lijuan Pang, Martin Smiesko, Brian Cutting, Oliver Schwardt, and Beat Ernst. FimH Antagonists for the Oral Treatment of Urinary Tract Infections: From Design and Synthesis to in Vitro and in Vivo Evaluation. Journal of Medicinal Chemistry 2010, 53 (24) , 8627-8641.
    29. Alan R. Katritzky, Minati Kuanar, Svetoslav Slavov, and C. Dennis Hall , Mati Karelson, Iiris Kahn, and Dimitar A. Dobchev . Quantitative Correlation of Physical and Chemical Properties with Chemical Structure: Utility for Prediction. Chemical Reviews 2010, 110 (10) , 5714-5789.
    30. Alex Avdeef and Kin Y. Tam . How Well Can the Caco-2/Madin−Darby Canine Kidney Models Predict Effective Human Jejunal Permeability?. Journal of Medicinal Chemistry 2010, 53 (9) , 3566-3584.
    31. Xinyuan Zhang, Nan Zheng, Peng Zou, Huaning Zhu, Juan P. Hinestroza and Gus R. Rosania . Cells on Pores: A Simulation-Driven Analysis of Transcellular Small Molecule Transport. Molecular Pharmaceutics 2010, 7 (2) , 456-467.
    32. Zhaoning Zhu, Zhong-Yue Sun, Yuanzan Ye, Johannes Voigt, Corey Strickland, Elizabeth M. Smith, Jared Cumming, Lingyan Wang, Jesse Wong, Yu-Sen Wang, Daniel F. Wyss, Xia Chen, Reshma Kuvelkar, Matthew E. Kennedy, Leonard Favreau, Eric Parker, Brian A. McKittrick, Andrew Stamford, Michael Czarniecki, William Greenlee and John C. Hunter . Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation. Journal of Medicinal Chemistry 2010, 53 (3) , 951-965.
    33. Manthena V. S. Varma, Bo Feng, R. Scott Obach, Matthew D. Troutman, Jonathan Chupka, Howard R. Miller and Ayman El-Kattan. Physicochemical Determinants of Human Renal Clearance. Journal of Medicinal Chemistry 2009, 52 (15) , 4844-4852.
    34. T. Knutson, P. Fridblom, H. Ahlström, A. Magnusson, C. Tannergren and H. Lennernäs . Increased Understanding of Intestinal Drug Permeability Determined by the LOC-I-GUT Approach Using Multislice Computed Tomography. Molecular Pharmaceutics 2009, 6 (1) , 2-10.
    35. M. Karthikeyan and S. Krishnan, Anil Kumar Pandey, Andreas Bender, Alexander Tropsha. Distributed Chemical Computing Using ChemStar: An Open Source Java Remote Method Invocation Architecture Applied to Large Scale Molecular Data from PubChem. Journal of Chemical Information and Modeling 2008, 48 (4) , 691-703.
    36. Tingjun Hou, , Junmei Wang, , Youyong Li. ADME Evaluation in Drug Discovery. 8. The Prediction of Human Intestinal Absorption by a Support Vector Machine. Journal of Chemical Information and Modeling 2007, 47 (6) , 2408-2415.
    37. I-Jen Chen,, Rajneesh Taneja,, Daxu Yin,, Paul R. Seo,, David Young,, Alexander D. MacKerell, Jr., and, James E. Polli. Chemical Substituent Effect on Pyridine Permeability and Mechanistic Insight from Computational Molecular Descriptors. Molecular Pharmaceutics 2006, 3 (6) , 745-755.
    38. Toshihide Takagi,, Chandrasekharan Ramachandran,, Marival Bermejo,, Shinji Yamashita,, Lawrence X. Yu, and, Gordon L. Amidon. A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan. Molecular Pharmaceutics 2006, 3 (6) , 631-643.
    39. Jae-Seung Kim,, Stefanie Mitchell,, Paul Kijek,, Yasuhiro Tsume,, John Hilfinger, and, Gordon L. Amidon. The Suitability of an in Situ Perfusion Model for Permeability Determinations:  Utility for BCS Class I Biowaiver Requests. Molecular Pharmaceutics 2006, 3 (6) , 686-694.
    40. Xinyuan Zhang,, Kerby Shedden, and, Gus R. Rosania. A Cell-Based Molecular Transport Simulator for Pharmacokinetic Prediction and Cheminformatic Exploration. Molecular Pharmaceutics 2006, 3 (6) , 704-716.
    41. Christian Sköld,, Susanne Winiwarter,, Johan Wernevik,, Fredrik Bergström,, Leif Engström,, Ruth Allen,, Karl Box,, John Comer,, Jon Mole,, Anders Hallberg,, Hans Lennernäs,, Torbjörn Lundstedt,, Anna-Lena Ungell, and, Anders Karlén. Presentation of a Structurally Diverse and Commercially Available Drug Data Set for Correlation and Benchmarking Studies. Journal of Medicinal Chemistry 2006, 49 (23) , 6660-6671.
    42. Johanna Linnankoski,, Johanna M Mäkelä,, Veli-Pekka Ranta,, Arto Urtti, and, Marjo Yliperttula. Computational Prediction of Oral Drug Absorption Based on Absorption Rate Constants in Humans. Journal of Medicinal Chemistry 2006, 49 (12) , 3674-3681.
    43. Ron Jones,, Paul C. Connolly,, Andreas Klamt, and, Michael Diedenhofen. Use of Surface Charges from DFT Calculations To Predict Intestinal Absorption. Journal of Chemical Information and Modeling 2005, 45 (5) , 1337-1342.
    44. Hanne H. F. Refsgaard,, Berith F. Jensen,, Per B. Brockhoff,, Søren B. Padkjær,, Mette Guldbrandt, and, Michael S. Christensen. In Silico Prediction of Membrane Permeability from Calculated Molecular Parameters. Journal of Medicinal Chemistry 2005, 48 (3) , 805-811.
    45. Pär Matsson,, Christel A. S. Bergström,, Naoki Nagahara,, Staffan Tavelin,, Ulf Norinder, and, Per Artursson. Exploring the Role of Different Drug Transport Routes in Permeability Screening. Journal of Medicinal Chemistry 2005, 48 (2) , 604-613.
    46. Igor V. Tetko and, Gennadiy I. Poda. Application of ALOGPS 2.1 to Predict log D Distribution Coefficient for Pfizer Proprietary Compounds. Journal of Medicinal Chemistry 2004, 47 (23) , 5601-5604.
    47. Anders Lindahl,, Åsa Sjöberg,, Ulf Bredberg,, Helena Toreson,, Anna-Lena Ungell, and, Hans Lennernäs. Regional Intestinal Absorption and Biliary Excretion of Fluvastatin in the Rat:  Possible Involvement of mrp2. Molecular Pharmaceutics 2004, 1 (5) , 347-356.
    48. Jörg K. Wegner,, Holger Fröhlich, and, Andreas Zell. Feature Selection for Descriptor Based Classification Models. 2. Human Intestinal Absorption (HIA). Journal of Chemical Information and Computer Sciences 2004, 44 (3) , 931-939.
    49. Jeyanthi Chinnappa Thenmozhiyal,, Peter Tsun-Hon Wong, and, Wai-Keung Chui. Anticonvulsant Activity of Phenylmethylenehydantoins:  A Structure−Activity Relationship Study. Journal of Medicinal Chemistry 2004, 47 (6) , 1527-1535.
    50. Nehal A. Kasim,, Marc Whitehouse,, Chandrasekharan Ramachandran,, Marival Bermejo,, Hans Lennernäs,, Ajaz S. Hussain,, Hans E. Junginger,, Salomon A. Stavchansky,, Kamal K. Midha,, Vinod P. Shah, and, Gordon L. Amidon. Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification. Molecular Pharmaceutics 2004, 1 (1) , 85-96.
    51. Artem Cherkasov,, Dennis G. Sprous, and, Ridong Chen. Three-Dimensional Correlation AnalysisA Novel Approach to the Quantification of Substituent Effects. The Journal of Physical Chemistry A 2003, 107 (45) , 9695-9704.
    52. Christel A. S. Bergström,, Melissa Strafford,, Lucia Lazorova,, Alex Avdeef,, Kristina Luthman, and, Per Artursson. Absorption Classification of Oral Drugs Based on Molecular Surface Properties. Journal of Medicinal Chemistry 2003, 46 (4) , 558-570.
    53. Li Xing and, Robert C. Glen. Novel Methods for the Prediction of logP, pKa, and logD. Journal of Chemical Information and Computer Sciences 2002, 42 (4) , 796-805.
    54. Mei Liu,, Prapon Wilairat, and, Mei-Lin Go. Antimalarial Alkoxylated and Hydroxylated Chalones:  Structure−Activity Relationship Analysis. Journal of Medicinal Chemistry 2001, 44 (25) , 4443-4452.
    55. Franco Lombardo,, Marina Y. Shalaeva,, Karl A. Tupper, and, Feng Gao. ElogDoct:  A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds. Journal of Medicinal Chemistry 2001, 44 (15) , 2490-2497.
    56. Patric Stenberg,, Ulf Norinder,, Kristina Luthman, and, Per Artursson. Experimental and Computational Screening Models for the Prediction of Intestinal Drug Absorption. Journal of Medicinal Chemistry 2001, 44 (12) , 1927-1937.
    57. Han van de Waterbeemd,, Dennis A. Smith,, Kevin Beaumont, and, Don K. Walker. Property-Based Design:  Optimization of Drug Absorption and Pharmacokinetics. Journal of Medicinal Chemistry 2001, 44 (9) , 1313-1333.
    58. Frank Wohnsland and, Bernard Faller. High-Throughput Permeability pH Profile and High-Throughput Alkane/Water log P with Artificial Membranes. Journal of Medicinal Chemistry 2001, 44 (6) , 923-930.
    59. William J. Egan,, Kenneth M. Merz, Jr., and, John J. Baldwin. Prediction of Drug Absorption Using Multivariate Statistics. Journal of Medicinal Chemistry 2000, 43 (21) , 3867-3877.
    60. Peter Ertl,, Bernhard Rohde, and, Paul Selzer. Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties. Journal of Medicinal Chemistry 2000, 43 (20) , 3714-3717.
    61. Ernest Danelian,, Anders Karlén,, Robert Karlsson,, Susanne Winiwarter,, Anna Hansson,, Stefan Löfås,, Hans Lennernäs, and, Markku D. Hämäläinen. SPR Biosensor Studies of the Direct Interaction between 27 Drugs and a Liposome Surface:  Correlation with Fraction Absorbed in Humans. Journal of Medicinal Chemistry 2000, 43 (11) , 2083-2086.
    62. Lene Hjorth Alifrangis,, Inge T. Christensen,, Anders Berglund,, Maria Sandberg,, Lars Hovgaard, and, Sven Frokjaer. Structure−Property Model for Membrane Partitioning of Oligopeptides. Journal of Medicinal Chemistry 2000, 43 (1) , 103-113.
    63. Stephanie Zhang, Whitney Ong, Natalia Subelzu, John Gleeson. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs. International Journal of Pharmaceutics 2024, 12 , 124089.
    64. Norma Flores-Holguín, Joan S. Salas-Leiva, Erick J. Núñez-Vázquez, Dariel Tovar-Ramírez, Daniel Glossman-Mitnik. Marine Toxins as Pharmaceutical Treasure Troves: A Focus on Saxitoxin Derivatives from a Computational Point of View. Molecules 2024, 29 (1) , 275.
    65. Larissa L. Silva, Robert E. Stratford, Richard Messmann, Mark R. Kelley, Sara K. Quinney. Bridging population pharmacokinetic and semimechanistic absorption modeling of APX3330. CPT: Pharmacometrics & Systems Pharmacology 2024, 13 (1) , 106-117.
    66. Marival Bermejo, Irene Camara-Martinez, Barbará Sanchez-Dengra, Alejandro Ruiz-Picazo, Isabel Gonzalez-Alvarez, Marta Gonzalez-Alvarez. In silico, in situ, in vitro, and in vivo predictive methods for modeling formulation performance. 2024, 67-116.
    67. Esteban Bertsch, Sebastián Suñer, Silvana Pinheiro, William J. Zamora. Critical Assessment of pH‐Dependent Lipophilicity Profiles of Small Molecules: Which One Should We Use and In Which Cases?. ChemPhysChem 2023, 24 (24)
    68. Tânia Martins, Tiago Ferreira, Bruno Colaço, Beatriz Medeiros-Fonseca, Maria de Lurdes Pinto, Ana Novo Barros, Carlos Venâncio, Eduardo Rosa, Luís Miguel Antunes, Paula Alexandra Oliveira, Maria João Pires. Absorption and Excretion of Glucosinolates and Isothiocyanates after Ingestion of Broccoli (Brassica oleracea L. var italica) Leaf Flour in Mice: A Preliminary Study. Nutraceuticals 2023, 3 (4) , 540-555.
    69. Sheena Sharma, Clark Kogan, Manthena V.S. Varma, Bhagwat Prasad. Analysis of the interplay of physiological response to food intake and drug properties in food-drug interactions. Drug Metabolism and Pharmacokinetics 2023, 53 , 100518.
    70. Jiang-Min Zhu, Chen Chen, Min Kong, Ling Zhu, Ya-Lin Li, Jian-Fei Zhang, Zhan-Peng Yu, Shi-Shu Xu, Ling-Yi Kong, Jian-Guang Luo. Discovery and optimization of indirubin derivatives as novel ferroptosis inducers for the treatment of colon cancer. European Journal of Medicinal Chemistry 2023, 261 , 115829.
    71. Stephanie Federico, Margherita Persico, Letizia Trevisan, Chiara Biasinutto, Giovanni Bolcato, Veronica Salmaso, Tatiana Da Ros, Teresa Gianferrara, Filippo Prencipe, Sonja Kachler, Karl‐Norbert Klotz, Sabrina Pacor, Stefano Moro, Giampiero Spalluto. [1,2,4]Triazolo[1,5‐ c ]pyrimidines as Tools to Investigate A 3 Adenosine Receptors in Cancer Cell Lines. ChemMedChem 2023, 18 (21)
    72. Barbara Wiśniowska, Susanne Linke, Sebastian Polak, Zofia Bielecka, Andreas Luch, Ralph Pirow. Data on ADME parameters of bisphenol A and its metabolites for use in physiologically based pharmacokinetic modelling. Data in Brief 2023, 48 , 109101.
    73. Patricia Muschong, Liang Jin, Jan Schejbal, Mario Mezler, Manuel Weinheimer. Improvement of Workflows and Assay Reproducibility by The Introduction of “Assay-Ready” Culturing of MDCK Cells for Transport Studies. Pharmaceutical Research 2023, 40 (5) , 1259-1270.
    74. Nannan Wang, Yunsen Zhang, Wei Wang, Zhuyifan Ye, Hongyu Chen, Guanghui Hu, Defang Ouyang. How can machine learning and multiscale modeling benefit ocular drug development?. Advanced Drug Delivery Reviews 2023, 196 , 114772.
    75. Sanwang Li, Feifan Xie. Foetal and neonatal exposure prediction and dosing evaluation for ampicillin using a physiologically‐based pharmacokinetic modelling approach. British Journal of Clinical Pharmacology 2023, 89 (4) , 1402-1412.
    76. Khairulanwar Burhanuddin, Raj Badhan. Optimising Fluvoxamine Maternal/Fetal Exposure during Gestation: A Pharmacokinetic Virtual Clinical Trials Study. Metabolites 2022, 12 (12) , 1281.
    77. José Iván Serrano-Contreras, María Estela Meléndez-Camargo, Yazmín Karina Márquez-Flores, Martha Patricia Soria-Serrano, María Elena Campos-Aldrete. Exploratory toxicology studies of 2,3-substituted imidazo[1,2- a ]pyridines with antiparasitic and anti-inflammatory properties. Toxicology Research 2022, 11 (5) , 730-742.
    78. Hiba Khalidi, Anthonia Onasanwo, Barira Islam, Heeseung Jo, Ciarán Fisher, Rich Aidley, Iain Gardner, Frederic Y. Bois. SimRFlow: An R-based workflow for automated high-throughput PBPK simulation with the Simcyp® simulator. Frontiers in Pharmacology 2022, 13
    79. Wei Wang, Defang Ouyang. Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery. Drug Discovery Today 2022, 27 (8) , 2100-2120.
    80. Udoamaka Ezuruike, Mian Zhang, Amita Pansari, Mailys De Sousa Mendes, Xian Pan, Sibylle Neuhoff, Iain Gardner. Guide to development of compound files for PBPK modeling in the Simcyp population‐based simulator. CPT: Pharmacometrics & Systems Pharmacology 2022, 11 (7) , 805-821.
    81. Yawen Yuan, Qingfeng He, Shunguo Zhang, Min Li, Zhijia Tang, Xiao Zhu, Zheng Jiao, Weimin Cai, Xiaoqiang Xiang. Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3Rs. Frontiers in Pharmacology 2022, 13
    83. Massimiliano Gaeta, Matteo Barcellona, Roberto Purrello, Maria Elena Fragalà, Alessandro D'Urso. Hybrid Porphyrin/DOPA-melanin film as self-assembled material and smart device for dye-pollutant removal in water. Chemical Engineering Journal 2022, 433 , 133262.
    84. Mahmoud E. Soliman, Adeniyi T. Adewumi, Oluwole B. Akawa, Temitayo I. Subair, Felix O. Okunlola, Oluwayimika E. Akinsuku, Shahzeb Khan. Simulation Models for Prediction of Bioavailability of Medicinal Drugs—the Interface Between Experiment and Computation. AAPS PharmSciTech 2022, 23 (3)
    85. Joseph P. O'Shea, Patrick Augustijns, Martin Brandl, David J. Brayden, Joachim Brouwers, Brendan T. Griffin, René Holm, Ann-Christin Jacobsen, Hans Lennernäs, Zahari Vinarov, Caitriona M. O'Driscoll. Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review. European Journal of Pharmaceutical Sciences 2022, 170 , 106098.
    86. Xuemei Wu, Xiaohan Zhang, Ruichao Xu, Imam Hussain Shaik, Raman Venkataramanan. Physiologically based pharmacokinetic modelling of treprostinil after intravenous injection and extended‐release oral tablet administration in healthy volunteers: An extrapolation to other patient populations including patients with hepatic impairment. British Journal of Clinical Pharmacology 2022, 88 (2) , 587-599.
    87. David Dahlgren, Hans Lennernäs. Oral Drug Delivery, Absorption and Bioavailability. 2022, 406-437.
    88. Harriet Bennett-Lenane, Brendan T. Griffin, Joseph P. O'Shea. Machine learning methods for prediction of food effects on bioavailability: A comparison of support vector machines and artificial neural networks. European Journal of Pharmaceutical Sciences 2022, 168 , 106018.
    89. Wei Wang, Zhuyifan Ye, Hanlu Gao, Defang Ouyang. Computational pharmaceutics - A new paradigm of drug delivery. Journal of Controlled Release 2021, 338 , 119-136.
    91. Masoud Hashemi, Alireza Zali, Ebrahim Golmakani, Mohammad Hossein Delshad, Mahdi Shadnoush, Mohammad-Esmaeil Akbari. Efficacy, safety, and tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study. DARU Journal of Pharmaceutical Sciences 2021, 29 (1) , 51-59.
    92. David Dahlgren, Tobias Olander, Markus Sjöblom, Mikael Hedeland, Hans Lennernäs. Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats. Acta Pharmaceutica Sinica B 2021, 11 (6) , 1667-1675.
    93. Arpar Ngampanya, Udomsak Udomnilobol, Pakawadee Sermsappasuk, Natapol Pornputtapong, Boonsri Ongpipattanakul, Nikunjkumar Patel, Suree Jianmongkol, Thomayant Prueksaritanont. Development and Qualification of a Physiologically Based Pharmacokinetic Model of Finasteride and Minoxidil Following Scalp Application. Journal of Pharmaceutical Sciences 2021, 110 (5) , 2301-2310.
    94. Mauricio A. García, Rodrigo Cristofoletti, Bertil Abrahamsson, Dirk W. Groot, Alan Parr, James E. Polli, Mehul Mehta, Vinod P. Shah, Tajiri Tomakazu, Jennifer B. Dressman, Peter Langguth. Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Carbamazepine. Journal of Pharmaceutical Sciences 2021, 110 (5) , 1935-1947.
    95. Tahnee J. Dening, Gregory E. Amidon, Xiaorong He, Michael J. Hageman. Physicochemical Characterization and Oral Dosage Form Design and Selection. 2021, 1-49.
    96. Arik Dahan, Gordon L. Amidon. Provisional BCS Classification of the Leading Oral Drugs on the Global Market. 2021, 1-14.
    97. Maria Alice Maciel Tabosa, Magdalena Hoppel, Annette L. Bunge, Richard H. Guy, M. Begoña Delgado-Charro. Predicting topical drug clearance from the skin. Drug Delivery and Translational Research 2021, 11 (2) , 729-740.
    98. Vamshi Krishna Jogiraju, Tycho Heimbach, Yuliana Toderika, David R. Taft. Physiologically based pharmacokinetic modeling of altered tizanidine systemic exposure by CYP1A2 modulation: Impact of drug-drug interactions and cigarette consumption. Drug Metabolism and Pharmacokinetics 2021, 37 , 100375.
    99. Emily J. Cox, Dan-Dan Tian, John D. Clarke, Allan E. Rettie, Jashvant D. Unadkat, Kenneth E. Thummel, Jeannine S. McCune, Mary F. Paine, . Modeling Pharmacokinetic Natural Product–Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach. Pharmacological Reviews 2021, 73 (2) , 847-859.
    100. Felix Stader, Perrine Courlet, Hannah Kinvig, Manuel Battegay, Laurent A. Decosterd, Melissa A. Penny, Marco Siccardi, Catia Marzolini. Effect of ageing on antiretroviral drug pharmacokinetics using clinical data combined with modelling and simulation. British Journal of Clinical Pharmacology 2021, 87 (2) , 458-470.
    Load more citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect